Review



dx eplex blood culture identification gram-negative (bcid-gn) panel  (GenMark Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GenMark Diagnostics dx eplex blood culture identification gram-negative (bcid-gn) panel
    Dx Eplex Blood Culture Identification Gram Negative (Bcid Gn) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dx+eplex+blood+culture+identification+(bcid)+gram-negative+(bcid-gn)+panel/dx+eplex+blood+culture+identification+gram+negative++bcid+gn++panel/med_rxiv__2022__12__22__22283612-30-11-10
    Average 90 stars, based on 1 article reviews
    dx eplex blood culture identification gram-negative (bcid-gn) panel - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Diagnostic Assay:

    Article Title: Prevalence of <i>bla</i> <sub>CTX-M</sub> Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States
    Article Snippet: Twenty-four microbiology laboratories representing 66 hospitals using the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel extracted blood culture results from April 2019 to July 2020.

    Article Title: Prevalence of <i>bla</i> <sub>CTX-M</sub> Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States
    Article Snippet: We identified 43 U.S. clinical microbiology laboratories that (as of July 2020) were using the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel and invited them to participate in the proposed work.

    Article Title: Risk Factor Analysis for Extended-Spectrum Beta-Lactamase Producing Enterobacterales Colonization or Infection: Evaluation of a Novel Approach to Assess Local Prevalence as a Risk Factor
    Article Snippet: Blood cultures growing a Gram-negative organism underwent testing with the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel.

    Article Title: A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
    Article Snippet: We report the results of a multicenter clinical study assessing the performance of the GenMark Dx ePlex investigational-use-only blood culture identification Gram-negative panel (BCID-GN), a rapid diagnostic assay for detection of bloodstream pathogens in positive blood culture (PBC) bottles.

    Bla VIM Assay:

    Article Title: Prevalence of <i>bla</i> <sub>CTX-M</sub> Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States
    Article Snippet: Twenty-four microbiology laboratories representing 66 hospitals using the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel extracted blood culture results from April 2019 to July 2020.

    Article Title: Prevalence of <i>bla</i> <sub>CTX-M</sub> Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States
    Article Snippet: We identified 43 U.S. clinical microbiology laboratories that (as of July 2020) were using the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel and invited them to participate in the proposed work.

    Article Title: Risk Factor Analysis for Extended-Spectrum Beta-Lactamase Producing Enterobacterales Colonization or Infection: Evaluation of a Novel Approach to Assess Local Prevalence as a Risk Factor
    Article Snippet: Blood cultures growing a Gram-negative organism underwent testing with the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel.

    Article Title: A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
    Article Snippet: We report the results of a multicenter clinical study assessing the performance of the GenMark Dx ePlex investigational-use-only blood culture identification Gram-negative panel (BCID-GN), a rapid diagnostic assay for detection of bloodstream pathogens in positive blood culture (PBC) bottles.

    Marker:

    Article Title: Prevalence of <i>bla</i> <sub>CTX-M</sub> Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States
    Article Snippet: Twenty-four microbiology laboratories representing 66 hospitals using the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel extracted blood culture results from April 2019 to July 2020.

    Article Title: Prevalence of <i>bla</i> <sub>CTX-M</sub> Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States
    Article Snippet: We identified 43 U.S. clinical microbiology laboratories that (as of July 2020) were using the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel and invited them to participate in the proposed work.

    Article Title: Risk Factor Analysis for Extended-Spectrum Beta-Lactamase Producing Enterobacterales Colonization or Infection: Evaluation of a Novel Approach to Assess Local Prevalence as a Risk Factor
    Article Snippet: Blood cultures growing a Gram-negative organism underwent testing with the GenMark Dx ePlex blood culture identification Gram-negative (BCID-GN) panel.

    Article Title: A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
    Article Snippet: We report the results of a multicenter clinical study assessing the performance of the GenMark Dx ePlex investigational-use-only blood culture identification Gram-negative panel (BCID-GN), a rapid diagnostic assay for detection of bloodstream pathogens in positive blood culture (PBC) bottles.



    Similar Products

    90
    GenMark Diagnostics dx eplex blood culture identification gram-negative (bcid-gn) panel
    Dx Eplex Blood Culture Identification Gram Negative (Bcid Gn) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dx+eplex+blood+culture+identification+(bcid)+gram-negative+(bcid-gn)+panel/dx+eplex+blood+culture+identification+gram+negative++bcid+gn++panel/med_rxiv__2022__12__22__22283612-30-11-10
    Average 90 stars, based on 1 article reviews
    dx eplex blood culture identification gram-negative (bcid-gn) panel - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GenMark Diagnostics dx eplex investigational-use-only (iuo) blood culture identification gram-negative panel (bcid-gn)
    Dx Eplex Investigational Use Only (Iuo) Blood Culture Identification Gram Negative Panel (Bcid Gn), supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dx+eplex+blood+culture+identification+(bcid)+gram-negative+(bcid-gn)+panel/dx+iuo+bcid+gp+panel/10__1128_slash_jcm__02484___20-30-17-16
    Average 90 stars, based on 1 article reviews
    dx eplex investigational-use-only (iuo) blood culture identification gram-negative panel (bcid-gn) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GenMark Diagnostics dx eplex blood culture identification (bcid) gram-negative (bcid-gn) panel
    Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
    Dx Eplex Blood Culture Identification (Bcid) Gram Negative (Bcid Gn) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dx+eplex+blood+culture+identification+(bcid)+gram-negative+(bcid-gn)+panel/eplex+blood+culture+panels/pmc08370220-142-2-1
    Average 90 stars, based on 1 article reviews
    dx eplex blood culture identification (bcid) gram-negative (bcid-gn) panel - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

    doi: 10.1128/AAC.00441-21

    Figure Lengend Snippet: Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

    Article Snippet: The GenMark Dx ePlex blood culture identification (BCID) (research use only) Gram-positive (BCID-GP) and Gram-negative (BCID-GN) panels were used for retained blood samples that were frozen at −80°C.

    Techniques: Comparison

    Comparison of RDT platforms

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

    doi: 10.1128/AAC.00441-21

    Figure Lengend Snippet: Comparison of RDT platforms

    Article Snippet: The GenMark Dx ePlex blood culture identification (BCID) (research use only) Gram-positive (BCID-GP) and Gram-negative (BCID-GN) panels were used for retained blood samples that were frozen at −80°C.

    Techniques: Comparison, Bacteria